ReviewCureus2026
Role of Grey Scale and Color Doppler in the Diagnosis of Portal Hypertension: A Comprehensive Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Portal hypertension represents a central haemodynamic abnormality in chronic liver disease and is responsible for major complications such as variceal bleeding, ascites, splenomegaly, hepatorenal dysfunction, and hepatic encephalopathy. Current non-invasive imaging contributes substantially to early diagnosis and follow-up; ultrasound (grey scale and colour Doppler) is the most commonly performed modality due to the availability of real-time haemodynamic monitoring and its ability to detect structural and functional derangements. These modalities allow real-time visualisation of portal venous anatomy and dynamic assessment of flow direction, velocity, and collateral circulation, while also capturing parenchymal alterations that reflect disease severity. Although operator dependence and technical limitations can affect diagnostic accuracy, recent advances, including contrast-enhanced ultrasonography, elastography, tissue harmonic imaging, and AI-assisted flow analysis, have markedly strengthened the non-invasive evaluation of portal hypertension. This narrative review synthesises the current evidence on the anatomical and haemodynamic basis of portal hypertension, the diagnostic role of grey-scale and colour Doppler ultrasound, advanced sonographic tools, and evolving technologies that promise to refine prognostication and therapeutic monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.